Orally available micelle-type branched-chain amino acid prodrug
Polymeric nanoparticles with high specificity compared to an existing drug
Dichloroacetate nanoparticle accumulates in cancer tissue by EPR effect.
Mucin secretion promotion for enhancement of intestinal epithelial barrier function by EPA metabolites produced by intestinal bacteria.
A drug candidate for the treatment of various fibrosis, incorporating a ligand for RIG-I, a pattern recognition receptor, as the active ingredient.
Estimation of hyperglycemia accumulated in the body as metabolic memory.
Lipid nanoparticles produced using Solvent X in the solvent dilution method achieved about 10-fold luciferase expression in vivo when administered.
Induces migration of newly generated neurons to the injured area by improving the microenvironment of injured brain tissue.
Cell therapy for filamentous fungal infections based on an innovative expanded culture of gamma-delta (γδ) T cells.